Tarceva is a new ORAL treatment for lung cancer

September 2005

Tarceva is a new ORAL treatment for lung cancer in Canada.

It's for patients with locally advanced or metastatic non-small-cell lung cancer who have failed at least ONE other chemo.

It works similar to Iressa (gefitinib)...but ONLY Tarceva (erlotinib) has been shown to improve survival.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

what privacy laws allow when discussing drug therapy
Neurology & Pain Tramacet is a new centrally-acting analgesic
Women's Health Evra contraceptive patch and reports of deaths due to blood clots
Women's Health which drugs decrease the efficacy of oral contraceptives
Insomnia You'll hear about an entirely new class of sleeping pills called melatonin receptor agonists
Diabetes two new investigational drugs for diabetes
appropriate use of long-acting inhaled beta-agonists for asthma
alternatives to pseudoephedrine
Supplements A new study is raising the question of whether echinacea is useful for the common cold
Supplements how ginkgo interacts with other drugs
Cholesterol different formulations of fenofibrate
Hematology & Oncology Tarceva is a new ORAL treatment for lung cancer
Pediatrics whether autism is caused by thimerosal in vaccines
Infectious Diseases new guidelines for the 2005-2006 flu season
Practice higher risk of hypertension in women taking chronic NSAIDs or acetaminophen